JCC:炎症性肠病完全结肠切除术后结肠外癌风险分析

2020-06-28 MedSci原创 MedSci原创

炎症性肠病患者罹患结肠外癌的风险增加。目前williamhill asia 对于全结肠切除术后[TC]的这种风险知之甚少。

背景

炎症性肠病患者罹患结肠外癌的风险增加。目前williamhill asia 对于全结肠切除术后[TC]的这种风险知之甚少。

 

方法

研究人员从丹麦国家患者登记处确定了在1977-2013年间接受过TC治疗的炎症性肠病的患者。结肠外癌的发病率是通过与丹麦癌症登记处的记录联系来确定的,并与普通人群的预期发病率进行比较。标准化的发病率[SIR]计算为观察到的与预期的癌症发生率之比。

 

结果

本项研究总共接受了4430例患者(3441例溃疡性结肠炎[UC]; 989例克罗恩病[CD]),随访TC后54183人年。手术后,有372名患者被诊断患有结肠外癌,而预期为331名[SIR = 1.1(95%置信区间{CI}:1.0–1.2)]。CD和TC患者的总体结肠外癌风险增加(SIR = 1.5 [95%CI:1.2–1.8]),但UC和TC患者未增加(SIR = 1.0 [95%CI:0.9–1.2] )。UC和TC患者患肠外结肠癌的风险更高(SIR = 2.0 [95%CI:1.4-2.7])。CD和TC患者患吸烟相关癌症(SIR = 1.9 [95%CI:1.2–2.9]),肠道结肠外癌(SIR = 3.1 [95%CI:1.6–5.5])和免疫介导的风险较高。

 

结论

与普通人群相比,CD行TC患者总体上患有结肠外癌的风险更高,而UC行TC患者则没有。

原始出处:

Anders Mark-Christensen. Et al. Extracolonic Cancer Risk After Total Colectomy for Inflammatory Bowel Disease: A Population-based Cohort Study. Journal of Crohn's and Colitis.2020.

本文由williamhill asia 医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1706560, encodeId=f1ea1e06560fc, content=<a href='/topic/show?id=0df2e87477d' target=_blank style='color:#2F92EE;'>#结肠切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78747, encryptionId=0df2e87477d, topicName=结肠切除术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a89f31292094, createdName=12498568m60暂无昵称, createdTime=Sat Jan 02 08:13:53 CST 2021, time=2021-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2061946, encodeId=4ee4206194699, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sat Dec 26 17:13:53 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877297, encodeId=127718e729779, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Wed Jul 08 11:13:53 CST 2020, time=2020-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547342, encodeId=37f1154e34245, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Tue Jun 30 02:13:53 CST 2020, time=2020-06-30, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1706560, encodeId=f1ea1e06560fc, content=<a href='/topic/show?id=0df2e87477d' target=_blank style='color:#2F92EE;'>#结肠切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78747, encryptionId=0df2e87477d, topicName=结肠切除术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a89f31292094, createdName=12498568m60暂无昵称, createdTime=Sat Jan 02 08:13:53 CST 2021, time=2021-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2061946, encodeId=4ee4206194699, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sat Dec 26 17:13:53 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877297, encodeId=127718e729779, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Wed Jul 08 11:13:53 CST 2020, time=2020-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547342, encodeId=37f1154e34245, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Tue Jun 30 02:13:53 CST 2020, time=2020-06-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1706560, encodeId=f1ea1e06560fc, content=<a href='/topic/show?id=0df2e87477d' target=_blank style='color:#2F92EE;'>#结肠切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78747, encryptionId=0df2e87477d, topicName=结肠切除术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a89f31292094, createdName=12498568m60暂无昵称, createdTime=Sat Jan 02 08:13:53 CST 2021, time=2021-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2061946, encodeId=4ee4206194699, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sat Dec 26 17:13:53 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877297, encodeId=127718e729779, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Wed Jul 08 11:13:53 CST 2020, time=2020-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547342, encodeId=37f1154e34245, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Tue Jun 30 02:13:53 CST 2020, time=2020-06-30, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1706560, encodeId=f1ea1e06560fc, content=<a href='/topic/show?id=0df2e87477d' target=_blank style='color:#2F92EE;'>#结肠切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78747, encryptionId=0df2e87477d, topicName=结肠切除术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a89f31292094, createdName=12498568m60暂无昵称, createdTime=Sat Jan 02 08:13:53 CST 2021, time=2021-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2061946, encodeId=4ee4206194699, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sat Dec 26 17:13:53 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877297, encodeId=127718e729779, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Wed Jul 08 11:13:53 CST 2020, time=2020-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547342, encodeId=37f1154e34245, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Tue Jun 30 02:13:53 CST 2020, time=2020-06-30, status=1, ipAttribution=)]

相关威廉亚洲官网

JCC:炎症性肠病患者后代出生缺陷的风险分析

妊娠期炎症性肠病与出生缺陷之间的关系尚不清楚。本项研究评估了孕妇的克罗恩氏病和溃疡性结肠炎是否与后代有先天缺陷的风险有关。

JCC:阿片类药物使用紊乱增加了炎症性肠病患者的30天再入院风险

近年来,随着对阿片类药物的使用不断增加,尤其是在患有慢性疼痛的炎性肠病[IBD]患者中,阿片类药物的流行已引起越来越多的关注。

IBD: 炎性肠病患者发生喉癌的危险因素及预后

有研究报道,炎症性肠病(IBD)患者发生肠外恶性肿瘤的风险增加,这主要是由于免疫抑制药物引起的。尤其是在免疫抑制的移植患者中发生头颈癌的风险增加。

IBD:减肥手术对炎症性肠病长期病程的影响

炎症性肠病(IBD)与肥胖之间存在关联。体重减轻对IBD病程的影响知之甚少。本项研究的目的是确定减肥手术对肥胖型IBD,克罗恩病(CD)或溃疡性结肠炎(UC)肥胖患者长期临床病程的影响。

IBD:患有炎症性肠病的孕妇早期停用英夫利昔单抗的影响

患有炎症性肠病(IBD)的孕妇尽早停用英夫利昔单抗(IFX)可以降低胎儿在宫内暴露于该药物的风险,但可能增加疾病发作的风险,从而导致不良的妊娠结局。

JCC:在日本炎症性肠病患者中硫嘌呤增加淋巴瘤的风险

炎症性肠病患者可能会发生非黑素瘤皮肤癌和非霍奇金淋巴瘤,这可能与潜在疾病和治疗有关。本项研究评估了日本溃疡性结肠炎或克罗恩氏病患者中这些恶性肿瘤的发生率。